(888) 645-1617

Drugwatch Podcast

Listen to health care professionals share their expertise and tips to help you live a better life. Formerly known as Drugwatch Radio, the podcast also features the personal stories of everyday men and women who suffered life-changing side effects from drugs and devices.

Subscribe for Notifications

Meet your Host

Michelle Llamas
Michelle Llamas

Michelle is a writer and researcher for Drugwatch.com. She interviews medical experts, patient advocates and consumers affected by dangerous drugs and devices.

Latest Episodes

UCLA Orthopaedic Surgeon Discusses Hip Replacement Surgery and Implant Complications

Dr. Bert J. Thomas, orthopaedic surgeon and chief of Joint Replacement Service at UCLA Medical Center, recently phoned in from California to discuss hip replacement [...]

Go To Episode

Pelvic Floor Physical Therapist Offers Treatment Options for Women Suffering from Mesh

Amy Robinson of Clear Passage Physical Therapy recently phoned in from her clinic in Indiana to talk about pelvic floor physical therapy and how it [...]

Go To Episode

Survivor Condemns Transvaginal Mesh as ‘Genocide on Women’

Teresa and David Sawyer – founders of the nonprofit TVT-NO! – phoned in from their home in Ohio to talk to me about their experiences [...]

Go To Episode

Hip Expert Joyce Peterson Offers Helpful Advice to People Who May Have a Defective Hip Implant

Joyce Courtney-Peterson, hip implant expert and Patient Advocate, recently dropped by the Drugwatch Podcast studio to share her unique insight on hip implants. Courtney-Peterson speaks [...]

Go To Episode

Dr. Christopher Walker Offers Hope to Women Suffering from Transvaginal Mesh Complications

Drugwatch Podcast was privileged to have Dr. Christopher Walker of UroGyn Specialists of Florida in the studio to discuss women’s pelvic floor health and to [...]

Go To Episode
1 3 4

Sign Up for Drugwatch Podcast & Newsletter Alerts

Stay up to date on the latest podcast and drug and device news from Drugwatch.

    Thank You!

    You will now receive updates from Drugwatch.